Altimmune, Inc. (ALT)
5.51
-0.01
(-0.18%)
USD |
NASDAQ |
Dec 10, 15:04
Altimmune Total Assets (Quarterly): 218.45M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 739.42M |
| Eli Lilly & Co. | 114.94B |
| Pfizer Inc. | 208.73B |
| Terns Pharmaceuticals, Inc. | 301.65M |
| Rhythm Pharmaceuticals, Inc. | 506.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.85M |
| Shareholders Equity (Quarterly) | 185.60M |
| Debt to Equity Ratio | 0.0857 |
| Current Ratio | 17.18 |
| Net Debt Paydown Yield | -0.78% |